'Two-Hit' Hypothesis

Much of what scientists know about the origins of cancer and the role of tumor suppressors can be traced back 28 years to the elegant theory of cancer researcher Alfred G. Knudson. Widely thought to be one of the most significant theories in modern biology, Knudson's "two-hit" hypothesis was recognized Nov. 19 at the John Scott Awards in Philadelphia, along with the revolutionary research of Benoit Mandelbrot, the discoverer of the powerful mathematical laws governing fractal geometry and self-s

Written byEugene Russo
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Much of what scientists know about the origins of cancer and the role of tumor suppressors can be traced back 28 years to the elegant theory of cancer researcher Alfred G. Knudson. Widely thought to be one of the most significant theories in modern biology, Knudson's "two-hit" hypothesis was recognized Nov. 19 at the John Scott Awards in Philadelphia, along with the revolutionary research of Benoit Mandelbrot, the discoverer of the powerful mathematical laws governing fractal geometry and self-similarity.1


Alfred G. Knudson
For Knudson, now a senior member of the Institute for Cancer Research at the Fox Chase Cancer Center in Philadelphia, it's the latest of a long list of accolades. Past honors for his theory on the genetic and environmental basis of several common cancers include the 1997 Gairdner Foundation International Award and the 1998 Albert Lasker Clinical Medical Research Award.2

Even amid ongoing rumors of an impending Nobel, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies